Cardiometabolic Disorders: Cardiovascular Disease
Upon completion of this session, you should be able to:
1. Describe the differences in risk classification for women’s cardiovascular disease.
2. Conduct appropriate screenings including blood tests (CBC, HbA1C), lipid profiles, glucose tests, blood pressure and weight measurement on patients who may be at risk for CVD.
3. Describe current clinical interventions to treat modifiable and non-modifiable risk factors for CVD.
4. Differentiate specific issues, disease processes, and treatments based on ethnicity, gender and genetics.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Jeannette South-Paul, MD, FAAFP, Chair, Department of Family Medicine, University of Pittsburgh; UPMC Matilda Theiss Clinic, Pittsburgh
- 0.75 AAFP prescribed